Nivolumab versus chemotherapy in Japanese patients with advanced esophageal squamous cell carcinoma: a subgroup analysis of a multicenter, randomized, open-label, phase 3 trial (ATTRACTION-3)
暂无分享,去创建一个
Y. Doki | M. Okada | R. Ishihara | S. Motoyama | K. Chìn | Y. Hamamoto | Ken Kato | T. Ogata | M. Muto | Masanobu Takahashi | Y. Kitagawa | M. Tsuda | H. Kawakami | H. Hara | Y. Kubota | Y. Nakashima | S. Kadowaki | M. Kodani | K. Chin